Select Medical Holdings Files 8-K
Ticker: SEM · Form: 8-K · Filed: Nov 19, 2024 · CIK: 1320414
Sentiment: neutral
Topics: sec-filing, 8-k, reporting
Related Tickers: SEM
TL;DR
SELECT files 8-K, no major news.
AI Summary
Select Medical Holdings Corp. filed an 8-K on November 19, 2024, reporting other events and financial statements/exhibits. The filing does not contain specific financial details or significant corporate actions beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Select Medical Holdings Corp. to the SEC, without disclosing new material information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information that would impact the company's risk profile.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORP (company) — Registrant
- November 19, 2024 (date) — Date of earliest event reported
- 4714 Gettysburg Road (address) — Principal executive offices
- Mechanicsburg, PA 17055 (address) — Principal executive offices
- 717-972-1100 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Select Medical Holdings Corp.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of November 19, 2024.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is November 19, 2024.
Where are Select Medical Holdings Corporation's principal executive offices located?
Select Medical Holdings Corporation's principal executive offices are located at 4714 Gettysburg Road, Mechanicsburg, PA 17055.
What is the telephone number for Select Medical Holdings Corporation?
The telephone number for Select Medical Holdings Corporation is (717) 972-1100.
Does this 8-K filing disclose any new material financial information or significant corporate actions?
Based on the provided text, this 8-K filing appears to be a routine report and does not explicitly disclose new material financial information or significant corporate actions beyond standard reporting categories.
Filing Stats: 854 words · 3 min read · ~3 pages · Grade level 11.2 · Accepted 2024-11-19 08:38:16
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
Filing Documents
- tm2428815d1_8k.htm (8-K) — 31KB
- tm2428815d1_ex99-1.htm (EX-99.1) — 13KB
- tm2428815d1_ex99-2.htm (EX-99.2) — 94KB
- tm2428815d1_ex99-1img01.jpg (GRAPHIC) — 10KB
- tm2428815d1_ex99-1img02.jpg (GRAPHIC) — 4KB
- tm2428815d1_ex99-2img01.jpg (GRAPHIC) — 4KB
- tm2428815d1_ex99-2img02.jpg (GRAPHIC) — 3KB
- 0001104659-24-120386.txt ( ) — 364KB
- sem-20241119.xsd (EX-101.SCH) — 3KB
- sem-20241119_lab.xml (EX-101.LAB) — 33KB
- sem-20241119_pre.xml (EX-101.PRE) — 22KB
- tm2428815d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On November 19, 2024, Select Medical Holdings Corporation (the "Company") issued a press release announcing that it had determined the final distribution ratio relating to its previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") owned by the Company. The Distribution is expected to be made as of 5:00 p.m., New York City time, on November 25, 2024 to the Company's stockholders as of the close of business on November 18, 2024 (the "Record Date"). After the completion of the Distribution, the Company will no longer own any shares of Concentra's common stock. A copy of the press release announcing the final distribution ratio is attached hereto as Exhibit 99.1 and incorporated herein by reference. The Distribution will take place in the form of a pro rata common stock distribution to each of the Company's stockholder on the Record Date. As of the Record Date, the Company had 128,992,850 shares of common stock outstanding. Accordingly, based on such number, the Company's stockholders will receive 0.806971 shares of Concentra's common stock for every share of the Company's common stock held as of the Record Date. The final distribution ratio was calculated by dividing the 104,093,503 shares of Concentra's common stock to be distributed by the number of shares of the Company's common stock currently outstanding as of the Record Date. No fractional shares of Concentra's common stock will be distributed. Instead, the Company's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received. In connection with the Distribution, on November 19, 2024, the Company made available an information statement (the "Information Statement") to its stockholders as of the Record Date. The Information Statement contains a description of Concentra, the terms of the Distribution and certain U.S. federa
01 Financial
Item 9.01 Financial (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release, dated November 19, 2024 99.2 Information Statement, dated November 19, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SELECT MEDICAL HOLDINGS CORPORATION Date: November 19, 2024 By: /s/ Michael E. Tarvin Michael E. Tarvin Senior Executive Vice President, General Counsel and Secretary